Close Menu

NEW YORK – Using single-cell sequencing data, researchers from the University of Texas MD Anderson Cancer Center have begun to explore the clonal diversity and determine the evolution of acute myeloid leukemia.

By better understanding the heterogeneity of cancer cells, researchers can gain insight into both how cancer develops as well as which targeted treatments might be best used to treat it. To that end, researchers led by MD Anderson's Koichi Takahashi conducted single-cell sequencing of samples from more than 100 AML patients. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.

Sponsored by

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Sponsored by

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.